|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.270
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.232
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.216
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.215
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.200
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.199
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.195
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.195
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.194
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.194
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.194
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.193
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.187
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.184
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.180
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.172
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.171
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.168
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.160
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.160
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.157
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.155
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.154
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.150
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.145
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.142
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.139
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.139
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.137
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.134
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.133
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.129
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.128
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.128
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.119
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.115
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.114
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.114
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.112
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.108
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.108
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.108
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.107
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.107
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.105
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.105
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.101
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.100
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.100
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.100
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.099
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.099
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.098
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.098
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.097
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.096
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.095
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.095
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.095
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.094
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.094
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.094
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.088
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.088
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.087
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.086
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.086
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.085
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.084
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.084
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.083
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.082
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.081
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.081
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.080
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.080
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.080
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.079
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.079
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.078
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.078
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.078
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.077
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.077
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.076
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.076
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.075
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.074
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.074
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.073
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.073
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.072
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.072
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.072
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.072
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.071
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.071
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.070
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.070
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.070
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.070
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.069
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.069
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.069
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.068
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.068
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.067
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.067
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.066
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.066
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.065
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.065
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.065
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.065
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.064
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.064
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.064
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.064
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.063
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.063
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.063
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.063
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.062
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.061
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.061
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.061
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.061
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.060
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.060
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.059
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.059
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.058
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.058
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.058
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.058
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.058
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.058
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.057
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.057
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.057
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.057
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.057
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.056
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.056
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.056
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.056
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.055
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.055
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.055
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.055
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.054
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.054
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.054
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.054
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.054
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.054
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.053
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.053
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.053
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.053
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.053
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.053
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.052
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.052
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.052
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.051
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.051
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.051
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.050
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.050
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.050
|
|
|
|
dendritic spine development
|
GO:0060996 |
30 |
0.050
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.050
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.050
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.050
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.050
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.050
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.049
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.049
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.049
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.049
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.049
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.049
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.049
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.048
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.048
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.048
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.048
|
|
|
|
positive regulation of synapse assembly
|
GO:0051965 |
18 |
0.048
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.048
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.048
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.048
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.047
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.047
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.047
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.047
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.047
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.047
|
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.046
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.046
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.046
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.046
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.046
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.045
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.045
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.045
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.045
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.044
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.044
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.044
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.044
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.044
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.044
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.043
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.043
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.043
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.043
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.043
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.043
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
29 |
0.043
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.042
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.042
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.042
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.042
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.042
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.042
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.042
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.042
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.042
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.041
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.041
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.041
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.041
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.041
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.041
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.041
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.041
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.041
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.040
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.040
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.040
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.040
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.040
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.040
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.039
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.039
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.039
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.039
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.039
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.039
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.039
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.039
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.039
|
|
|
|
positive regulation of meiosis
|
GO:0045836 |
14 |
0.039
|
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.039
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.039
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.038
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.038
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.038
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.038
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.038
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.038
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.038
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.038
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.038
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.038
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.038
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.038
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.037
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.037
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.037
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.037
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.037
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.037
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.037
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.037
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.037
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.037
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.037
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.037
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.037
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.037
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.036
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.036
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.036
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.036
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.036
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.036
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.036
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.036
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.036
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.036
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.036
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.036
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.036
|
|
|
|
retinal bipolar neuron differentiation
|
GO:0060040 |
5 |
0.036
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.036
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.036
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.036
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.036
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.035
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.035
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.035
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.035
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.035
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.035
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.035
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.035
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.035
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.035
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.035
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.035
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.035
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.035
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.035
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.034
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.034
|
|
|
|
negative regulation of axon guidance
|
GO:1902668 |
8 |
0.034
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.034
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.034
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.034
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.034
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.034
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.034
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.034
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.034
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.034
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.033
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.033
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.033
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.033
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.033
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.033
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.033
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.033
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.033
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.033
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.033
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.033
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.033
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.033
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.033
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.033
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.033
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.033
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.032
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.032
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.032
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.032
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.032
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.032
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.032
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.032
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.032
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.032
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.032
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.032
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.032
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.032
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.032
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.032
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.032
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.032
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.032
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.032
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.032
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.032
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.032
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.032
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.032
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.031
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.031
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.031
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.031
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.031
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.031
|
|
|
|
trophoblast giant cell differentiation
|
GO:0060707 |
15 |
0.031
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.031
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.031
|
|
|
|
neuron fate specification
|
GO:0048665 |
30 |
0.031
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.031
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.031
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.031
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.031
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.030
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.030
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.030
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.030
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.030
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.030
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.030
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.030
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.030
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.030
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.030
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.030
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.030
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.029
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.029
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.029
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.029
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.029
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.029
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.029
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.029
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.029
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.029
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.029
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.029
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.029
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.029
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.029
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.029
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.029
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.028
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.028
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.028
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.028
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.028
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.028
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.028
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.028
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.028
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.028
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.028
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.028
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.028
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.028
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.028
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.028
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.028
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.028
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.028
|
|
|
|
positive regulation of dna templated transcription initiation
|
GO:2000144 |
5 |
0.028
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.028
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.028
|
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.028
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.027
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.027
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.027
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.027
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.027
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.027
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.027
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.027
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.027
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.027
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.027
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.027
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.027
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.027
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.027
|
|
|
|
neural crest cell migration
|
GO:0001755 |
32 |
0.027
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.027
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.027
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.027
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.027
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.027
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.027
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.027
|
|
|
|
enteroendocrine cell differentiation
|
GO:0035883 |
16 |
0.027
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.027
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.026
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.026
|
|
|
|
mesenchymal to epithelial transition
|
GO:0060231 |
12 |
0.026
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.026
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.026
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.026
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.026
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.026
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.026
|
|
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.026
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.026
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.026
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.026
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.026
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.026
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.026
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.026
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.026
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.026
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.025
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.025
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.025
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.025
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.025
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.025
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.025
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.025
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.025
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.025
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.025
|
|
|
|
morphogenesis of an epithelial fold
|
GO:0060571 |
28 |
0.025
|
|
